Prime Minister Mostafa Madbouli said the government is
keen to secure a safe and strategic stock of medicines and medical supplies,
stressing the continuous follow-up aims to ensure the stability of health
services provided to citizens and to prevent any shortages of vital medicines
in the domestic market.
Madbouli made these remarks on Monday, January 26,
2026, during his meeting with Minister of Health and Population Khaled Abdel
Ghaffar, Finance Minister Ahmed Kouchouk, Chairman of the Egyptian Drug
Authority (EDA) Ali El-Ghamrawy, and Chairman of the Egyptian Authority for
Unified Procurement, Medical Supply, and the Management of Medical Technology
(UPA) Hisham Stait, as well as Secretary-General of the Supreme Council of
University Hospitals Omar Sherif Omar and CEO of the Universal Health Insurance
Authority Mai Farid, said Spokesman for the Cabinet Mohamed El-Homosany.
The spokesman added that the meeting reviewed a report
on outstanding debts to pharmaceutical companies, reaffirming the State's
commitment to settling arrears in line with an agreed timetable.
The premier reiterated the government's support for
companies operating in this vital sector, ensuring the continuity of production
and supply without disruption.
As part of ongoing efforts to clear debts to
pharmaceutical companies, it was noted that the Ministry of Finance allocated
EGP 2.5 billion on Monday to the Unified Procurement Authority to make payments
to the sector. In addition, the Ministry of Health and Population paid EGP 1.7
billion on the same day, while the General Health Insurance Authority continues
to pay EGP 2 billion monthly.
Source: State Information Service